• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Innovation Partners

Innovation Partners

Healthcare Access Simplified

  • Home
  • About
  • Services
    • Payor and Market Access
    • Corporate and Patient Advocacy
    • Research and Forecasting
    • Healthcare Policy
    • Corporate Partnerships
  • Our Team
  • Our Partners
  • BioBlog
  • Contact
    • Get In Touch
    • Please Join Our Panel
    • Join Our Team
  • Community
    • Bridge 4 Hope

BioBlog

Innovation Partners Weekly BioBlog August 2, 2020

August 2, 2020

COVID-19 Therapeutics and More

The U.S. Department of Justice gave the green light for six pharmaceutical companies to share manufacturing data in the quest for COVID-19 therapeutics. The companies may not, however, share pricing information and production costs. And changes are happening in the world of oncology from a new

BioBlog

Innovation Partners Weekly curated BioBlog July 26

July 26, 2020

Novartis Q2 Sales Down, Pfizer and BioNTech Prepare for COVID-19 Vaccine Testing

This week's Innovation Partners BioBlog contains several updates from major players in the pharmaceutical industry. Novartis' sales dropped in the second quarter after early pandemic drug stockpiling boosted Q1 sales. The company is also struggling with unanticipated and serious side effects

BioBlog

Innovation Partners Weekly BioBlog July 19, 2020

July 19, 2020

A COVID-19 Vaccine by Early 2021?

U.S. health officials stated they expect to have 300 million doses of a vaccine for the novel coronavirus by early 2021 despite the fact that a final vaccine candidate has not been chosen. NCCN makes the case for biosimilars to help in the fight against cancer, and Roche is set to pay $775 million

BioBlog

Innovation Partners BioBlog July 12, 2020

July 12, 2020

Are We Close to a COVID-19 Vaccine Yet?

In this week’s Innovation Partners BioBlog, we take a look at several updates from companies and groups working on treatments and vaccines for the novel coronavirus. A bipartisan group seeks to protect hospitals from losing their 340B status due to lower inpatient hospital admissions from specific

BioBlog

Innovation Partners BioBlog July 5, 2020

July 5, 2020

Drug Prices Rise Despite the Pandemic; SCOTUS Takes on the ACA

Happy Independence Day to all of our American readers! In this week’s Innovation Partners BioBlog, we take a look at several updates from the pharmaceutical world. AstraZeneca is the first company to participate in a new FDA program to disclose all patient-reported symptoms during drug trials. The

BioBlog

Innovation Partners Weekly BioBlog June 28

June 28, 2020

Breakthroughs in Cancer Testing and Treatment

Breakthroughs announced this week at the AACR Virtual Meeting show that the pace of cancer diagnosis, testing, and treatment hasn't slowed despite the worldwide pandemic. Clinical trials of a new personalized cancer vaccine show promise, while researchers appear to have developed a blood test that

BioBlog

Innovation Partners BioBlog June 21

June 21, 2020

Oncology Update

This week’s Innovation Partners BioBlog focuses on oncology updates. NICE backs funding for Roche’s lung cancer drug, Rozlytrek, after the company offers discounts. New personalized oncology treatments may be available based on patients’ genetic profiles thanks to a partnership between MD Anderson

BioBlog

Innovation Partners Weekly BioBlog June 12

June 12, 2020

The Quest for a COVID-19 Therapy

In this week’s edition of the Innovation Partners BioBlog, we look at two stories related to pharmaceutical giant AstraZeneca. AstraZeneca has identified two potential antibodies against COVID-19 and expect to move them into the clinic by August. However, this means that AstraZeneca’s merger with

BioBlog

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

EXPLORE OUR SERVICES

  • Payor and Market Access
  • Corporate and Patient Advocacy
  • Research and Forecasting
  • Healthcare Policy
  • Corporate Partnerships

BIOBLOG Curated News

COVID-19 Therapeutics and More

The U.S. Department of Justice gave the green light for six pharmaceutical companies to share manufacturing data in the quest for COVID-19 therapeutics. The companies may not, however, share pricing information and production costs. And changes are happening in the world of oncology from a new

Footer

Contact Innovation Partners

Together We're Better

Contact us for more information or to get started.

Don't See What You Need?

Customized services to meet your goals.

Join Our Panel

Compensated market research-seeking panelists.

© 2021 · Innovation Partners · Privacy Policy